Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study

2021 ◽  
pp. 1-10
Author(s):  
Y Nakayama ◽  
M Hashimoto ◽  
R Watanabe ◽  
K Murakami ◽  
K Murata ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cohort Study ◽  
Clinical Response ◽  
Drug Retention ◽  
Favorable Clinical Response ◽  
Receptor Inhibitor

scholarly journals Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-

PLoS ONE ◽  
2018 ◽  
Vol 13 (3) ◽  
pp. e0194130 ◽  
Author(s):  
Kosuke Ebina ◽  
Motomu Hashimoto ◽  
Wataru Yamamoto ◽  
Akira Ohnishi ◽  
Daijiro Kabata ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cohort Study ◽  
Drug Retention

Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study

2021 ◽  
Author(s):  
Kosuke Ebina ◽  
Toru Hirano ◽  
Yuichi Maeda ◽  
Wataru Yamamoto ◽  
Motomu Hashimoto ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cohort Study ◽  
Drug Retention

scholarly journals Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study

2020 ◽  
Vol 22 (1) ◽  
Author(s):  
Kosuke Ebina ◽  
Toru Hirano ◽  
Yuichi Maeda ◽  
Wataru Yamamoto ◽  
Motomu Hashimoto ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cohort Study ◽  
Drug Retention

Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-

2020 ◽  
Vol 39 (9) ◽  
pp. 2563-2572 ◽  
Author(s):  
Kosuke Ebina ◽  
Toru Hirano ◽  
Yuichi Maeda ◽  
Wataru Yamamoto ◽  
Motomu Hashimoto ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cohort Study ◽  
Jak Inhibitors ◽  
Drug Retention
Sign in / Sign up

Export Citation Format

Share Document